Literature DB >> 11996679

Clonal groupings in serogroup X Neisseria meningitidis.

Sébastien Gagneux1, Thierry Wirth, Abraham Hodgson, Ingrid Ehrhard, Giovanna Morelli, Paula Kriz, Blaise Genton, Tom Smith, Fred Binka, Gerd Pluschke, Mark Achtman.   

Abstract

The genetic diversity of 134 serogroup X Neisseria meningitis isolates from Africa, Europe, and North America was analyzed by multilocus sequence typing and pulsed-field gel electrophoresis. Although most European and American isolates were highly diverse, one clonal grouping was identified in sporadic disease and carrier strains isolated over the last 2 decades in the United Kingdom, the Netherlands, Germany, and the United States. In contrast to the diversity in the European and American isolates, most carrier and disease isolates recovered during the last 30 years in countries in the African meningitis belt belonged to a second clonal grouping. During the last decade, these bacteria have caused meningitis outbreaks in Niger and Ghana. These results support the development of a comprehensive conjugate vaccine that would include serogroup X polysaccharide.

Entities:  

Mesh:

Year:  2002        PMID: 11996679      PMCID: PMC2732495          DOI: 10.3201/eid0805.010227

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Bacterial meningitis due to Neisseria meningitidis (meningococcus) causes epidemics in Africa usually associated with serogroup A meningococci. Sporadic cases, outbreaks, and hyperendemic disease in Europe and the United States are usually caused by serogroups B and C (. Occasionally, however, endemic disease and outbreaks are caused by bacteria belonging to other serogroups, including W135, Y, and X. Serogroup X N. meningitidis was described in the 1960s (,), and serogroup X meningitis has been observed in North America (, Europe (,), Australia (, and Africa (,). Serogroup X outbreaks have been reported in Niger (,) and Ghana . In some cases, serogroup X disease has been associated with a deficiency of particular complement components (,) or with AIDS (. Asymptomatic nasopharyngeal carriage of N. meningitidis is common, and in only a small percentage of colonized persons do the bacteria invade the bloodstream and cerebrospinal fluid to cause disease. Meningococcal populations are highly diverse, and lineages of meningococci with increased capacity to cause invasive disease are thought to arise periodically and spread, sometimes globally (. Relatively few of these hyperinvasive lineages or clonal groupings are responsible for most meningococcal disease worldwide (. These clonal groupings diversify during spread (,), primarily as a result of frequent horizontal genetic exchange (–). However, many variants are isolated only rarely or from a single country and are not transmitted further because of bottlenecks associated with geographic spread and competition (,). The population structure of N. meningitidis is effectively panmictic as a result of frequent horizontal genetic exchange (, but that of some groupings, such as epidemic serogroup A meningococci, is largely clonal (. The population structure of serogroup X meningococci has not yet been investigated in detail. After an epidemic of serogroup A disease in 1997-1998 in northern Ghana (, we conducted a longitudinal carriage study to investigate the dynamics of meningococcal carriage during an interepidemic period (. We observed a sharp increase in nasopharyngeal carriage of serogroup X meningococci by healthy persons, accompanied by several cases of serogroup X meningitis. To investigate the phylogenetic relationships of these bacteria, we compared the isolates from Ghana with other serogroup X meningococci isolated during recent decades in Africa, Europe, and North America.

Materials and Methods

Bacterial Strains

We analyzed 134 N. meningitidis isolates of serogroup X by pulsed-field gel electrophoresis (PFGE) (130 isolates) or multilocus sequence typing (MLST) (41 isolates). Of these bacteria, 102 were isolated in Africa from 1970 to 2000: from meningitis patients (9 isolates) and healthy carriers (70 isolates) in Ghana, 1998-2000; from healthy carriers in Mali in 1970 (9 isolates) and 1990-91 (4 isolates); and from patients in Chad (1995, 1 isolate), Niger (1997-1998, 4 isolates), and Burkina Faso (1996-1998, 5 isolates). Six isolates were not tested serologically; the other 96 were NT:P1.5. In addition, 32 serogroup X strains isolated from 1988 to 2000 in the United Kingdom (22 isolates), Germany (3 isolates), United States (4 isolates), France (1 isolate), Norway (1 isolate), and the Netherlands (1 isolate) were included in the analysis. The 26 strains subjected to further testing had diverse serotypes (2b, 4, 4/21, 14, 16, 21, 22) and serosubtypes (nonsubtypable [NST], P1.5, P1.5,10, P1.7, P1.12, P1.14, P1.15, P1.16) in various combinations.

Molecular Typing of Bacteria

PFGE was done by digesting chromosomal DNA prepared in agarose blocks with NheI and SpeI as described (, and MLST by sequencing gene fragments of abcZ, adk, aroE, fumC, gdh, pdhC, and pgm, also as described (16; http://www/mlst.net). The detailed MLST results and sources of isolates have been deposited in a public database http://www.mlst.net). Additional MLST data for 31 isolates in 30 sequence types were obtained with permission from http://www.mlst.net.

Data Analysis

A neighbor-joining tree was constructed by using the numbers of MLST allele differences with Bionumerics 2.0 .

Results

PFGE with two discriminatory rare-cutting enzymes NheI and SpeI) was used to identify groups of closely related strains in 134 isolates of serogroup X N. meningitidis from countries in Africa, Europe, and North America. All but 3 of 102 isolates from Africa had similar PFGE patterns (Figure 1, clonal grouping X-I). In contrast, 19 of 32 isolates from Europe and North America had distinct PFGE patterns (Figure 2) that differed from those of the African isolates. However, among the latter 32 strains, similar PFGE patterns were observed for 13 isolates from the United Kingdom, Germany, the Netherlands, and the United States (Figure 2, clonal grouping X-II).
Figure 1

Two groups of pulsed-field gel electrophoresis patterns among NheI- and SpeI-digested chromosomal DNA from selected serogroup X Neisseria meningitidis strains isolated in Africa. Lane: strain: 1: D93 (ST188); 2: 1970; 3: 3187; 4: 3529; 5: D5; 6: LNP13407; 7: LNP14964; 8: LNP15040; 9: 97013; 10: 97014; 11: Z9413; 12: LNP14297; 13: LNP15061; 14: BF2/97; 15: BF5/97; 16: BF1/98; 17: Z7091; 18: Z8336; 19: Z9291. Molecular weight markers were loaded in the flanking lanes as indicated (L: low-range marker; M: midrange marker); their molecular weights are indicated at the left. Characteristic band differences are indicated on the right.

Figure 2

Pulsed-field gel electrophoresis patterns of NheI-digested chromosomal DNA of selected serogroup X Neisseria meningitidis isolates from Europe and the United States, plus a prototype isolate from Ghana (lane 13). Lane: strain: 1: E26; 2: X4571; 3: X4890; 4: M2526; 5: M4222; 6: M3772; 7: LNP17351; 8: J88-603; 9: K89-1395; 10: L92-1413; 11: M98-253172; 12: M00-240465; 13: Z9291; 14: M98-252848; 15: M98-252718; 16: M99-240899; 17: X5967; 18: 860060; 19: M4370.

Two groups of pulsed-field gel electrophoresis patterns among NheI- and SpeI-digested chromosomal DNA from selected serogroup X Neisseria meningitidis strains isolated in Africa. Lane: strain: 1: D93 (ST188); 2: 1970; 3: 3187; 4: 3529; 5: D5; 6: LNP13407; 7: LNP14964; 8: LNP15040; 9: 97013; 10: 97014; 11: Z9413; 12: LNP14297; 13: LNP15061; 14: BF2/97; 15: BF5/97; 16: BF1/98; 17: Z7091; 18: Z8336; 19: Z9291. Molecular weight markers were loaded in the flanking lanes as indicated (L: low-range marker; M: midrange marker); their molecular weights are indicated at the left. Characteristic band differences are indicated on the right. Pulsed-field gel electrophoresis patterns of NheI-digested chromosomal DNA of selected serogroup X Neisseria meningitidis isolates from Europe and the United States, plus a prototype isolate from Ghana (lane 13). Lane: strain: 1: E26; 2: X4571; 3: X4890; 4: M2526; 5: M4222; 6: M3772; 7: LNP17351; 8: J88-603; 9: K89-1395; 10: L92-1413; 11: M98-253172; 12: M00-240465; 13: Z9291; 14: M98-252848; 15: M98-252718; 16: M99-240899; 17: X5967; 18: 860060; 19: M4370. Forty-one isolates, each representing a distinct PFGE pattern, were analyzed by MLST. For bacteria from which multiple isolates with a similar PFGE pattern had been detected, we tested at least one representative from each year and country of isolation. Together with other data in the MLST WEB site (http://www.mlst.net), 39 distinct sequence types (STs) have been found in 50 serogroup X meningococci. The general structure of a neighbor-joining tree of allelic differences resembles a bush, with little phylogenetic structure (Figure 3). However, isolates with similar PFGE patterns were assigned to closely related STs. All 29 clonal grouping X-I isolates analyzed by MLST were in STs ST181, ST182, or ST751 (Figure 3), which differ by one to three of the seven gene fragments (Table). Similarly, all five clonal grouping X-II isolates were in STs 24 and 750, which differ by one of the seven gene fragments (Table). The three unusual African isolates (strain designations D87, D91, and D93) were in ST188, which is very distinct from STs of clonal grouping X-I (Figure 3). These results show that numerous serogroup X isolates from Africa and nearly half the serogroup X isolates from Europe and North America belong to two clonal groupings, while other serogroup X isolates from Europe or North America are quite diverse.
Figure 3

Neighbor-joining phenogram of allelic identities in 39 multilocus sequence typing (MLST) sequence types from serogroup X Neisseria meningitidis. Numbers at nodes are the percentages of 1,000 bootstrap replicates in which these nodes appeared. Only nodes with percentages >50% were included. The two boxes indicate clonal groupings that were detected by MLST or pulsed-field gel electrophoresis.

Table

Multilocus sequence typing results of two serogroup X Neisseria meningitidis clonal groupings

STAllele numbersCountry (no. of isolates)Year
AbcZ Adk aroE FumC gdh pdhC Pgm
24252715205Netherlands (1), United States (1)1986, 1993
750252915205United Kingdom (2), Germany (1)1998-1999
18110315754131Mali (6), Chad (1), Niger (2), Ghana (1)1970-2000
182103152654131Mali (4)1970
7511031578416Burkina Faso (3), Ghana (12)1996-2000
Neighbor-joining phenogram of allelic identities in 39 multilocus sequence typing (MLST) sequence types from serogroup X Neisseria meningitidis. Numbers at nodes are the percentages of 1,000 bootstrap replicates in which these nodes appeared. Only nodes with percentages >50% were included. The two boxes indicate clonal groupings that were detected by MLST or pulsed-field gel electrophoresis.

Serologic Results

African isolates of clonal grouping X-I were NT:P1.5. The 11 North American and European isolates of clonal grouping X-II for which serologic data were available were 21:P1.16. Diverse serotype and serosubtype patterns were found for the other isolates from North America and Europe The PFGE patterns distinguished two finer groups (Ia and Ib) in clonal grouping X-I, which differ consistently in four NheI and three SpeI fragments (Figure 1). All 14 group Ia strains tested were either ST181 or ST182, which differ at one of the seven gene fragments (Table). All 15 group Ib strains tested were ST751, which differs from ST181 and ST182 at two to three loci (Table). Group Ia included 10 isolates from Mali (1970-1990), 4 isolates from Niger (1997-1998), and the sole isolate from Chad (1995), as well as one of 79 isolates from Ghana (2000). All five isolates from Burkina Faso (1996-1998) and 78 of 79 isolates from Ghana (1998-2000) were in group Ib.

Discussion

The general population structure of N. meningitidis is panmictic as a result of the frequent import of alleles from unrelated Neisseriae (,). Furthermore, several MLST studies have demonstrated that meningococci from healthy carriers are highly diverse (,). Phylogenetic trees of different housekeeping genes from N. meningitidis are no more congruent with each other than with random trees (. Our results for sequence typing of housekeeping genes of serogroup X meningococci also fit this pattern. Phylogenetic analysis of allele differences resulted in a bushlike tree that does not seem to contain any deep phylogenetic information. However, two clonal groupings were found in this otherwise panmictic group of bacteria. The same isolates were assigned to both clonal groupings by two independent methods, MLST and PFGE, indicating that these assignments reflect real genetic relationships and do not depend on the methods used. Similar concordant genetic relationships were discerned in epidemic serogroup A N. meningitidis by multilocus enzyme electrophoresis (MLEE), random amplification of polymorphic DNA (RAPD), and MLST; population genetic analyses confirmed that the population structure of these bacteria is clonal (. Concordant groupings were also discerned by MLEE and MLST among the so-called hypervirulent serogroup B and C isolates of the ET-5 complex, ET-37 complex, lineage III, and cluster A4 (. Although their apparent clonality may reflect an epidemic population structure (, this possibility has been excluded for epidemic serogroup A meningococci (. Therefore, multiple clonal groupings exist in N. meningitidis, even though the population structure of most of the species is panmictic. The population structure of subgroup III serogroup A meningococci seems to represent continual, sequential replacement of fit genotypes by related variants during periods of several years to decades (. In subgroup III, nine genoclouds, each consisting of a frequent genotype plus its rarer, less fit variants, have been identified during 3 decades of pandemic spread. Our PFGE data for clonal grouping I of serogroup X suggest that clonal grouping X-I also has a genocloud structure. Two sets of PFGE variants (group Ia and Ib), which might each represent a genocloud, were detected in different countries (Mali, Chad, and Niger; and Burkina Faso and Ghana, respectively). Additional analyses of polymorphic genes are necessary to clarify the uniformity of these groups and to test the similarity of their population structure compared with that of subgroup III. Both serogroup X clonal groupings described here were isolated over decades, on multiple occasions, and from diverse locations. Clonal grouping X-I (1970-2000) was isolated from different countries in West Africa, and clonal grouping X-II (1986-1999) was isolated from Europe and North America. For clonal grouping X-I in Ghana, the disease rate in healthy carriers was estimated to be 3/10,000 (12). Clonal grouping X-1 is thus of considerably lower virulence than serogroup B ET-5 complex bacteria (disease/carrier rate of 2,100/10,000 []) or serogroup A subgroup III bacteria during a postepidemic period in a vaccinated population (100/10,000 []). The relationship between bacterial fitness and clonality has not yet been investigated extensively in natural isolates. Variation in virulence between bacterial genotypes leads to more uniformity in disease isolates than in carriage organism in Streptococcus pneumoniae ( and Staphylococcus aureus (. However, our data suggest that the clonal structure of certain meningococcal genotypes need not reflect virulence but rather is associated with genotypes that are particularly fit at colonizing the nasopharynx and spreading from person to person. Although clonal grouping X-I bacteria are less virulent than serogroup A and B meningococci, they are still pathogenic. Most strains described here were isolated from asymptomatic carriers or patients with rare endemic cases. However, group Ia caused a meningitis outbreak with >60 cases in 1997 in Niger (. Group Ib caused a smaller outbreak in 2000 in Ghana (. These results suggest that X-I meningococci may even be capable of causing epidemics. Meningococci are naturally transformable, and horizontal DNA transfer is frequent in these bacteria (–). Meningococcal carriage is usually low in interepidemic periods in Africa (,,,), offering less opportunity for horizontal genetic exchange, which could account for the low genetic variability in serogroup X meningococci in Africa. For more than a decade, many countries in the African meningitis belt have vaccinated extensively with A/C polysaccharide vaccines (. Recently, mass vaccination with conjugated serogroup C vaccines has been implemented in the United Kingdom, and strong initial protection has been reported (. However, if effective, these vaccines may well select for the spread of bacteria for which they are not protective (, including unusual causes of disease such as serogroups Y, W135, and X. Capsule switching due to DNA transformation has been documented (,), and effective vaccination against serogroups A and C may select for capsule switch variants of fit genotypes expressing a capsular polysaccharide not included in the vaccination program. The recent outbreaks after the 2000 Hajj pilgrimage, caused by W135 ET-37 complex meningococci (,), may reflect exactly such selection. These findings support the development of comprehensive conjugate vaccines that include capsular polysaccharides from formerly rare causes of disease such as serogroup X.
  37 in total

1.  The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis.

Authors:  E C Holmes; R Urwin; M C Maiden
Journal:  Mol Biol Evol       Date:  1999-06       Impact factor: 16.240

2.  Rapid serogroup switching in Neisseria meningitidis.

Authors:  U Vogel; H Claus; M Frosch
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.

Authors:  M E Ramsay; N Andrews; E B Kaczmarski; E Miller
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

4.  Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread.

Authors:  G Morelli; B Malorny; K Müller; A Seiler; J F Wang; J del Valle; M Achtman
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

5.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  How clonal are bacteria?

Authors:  J M Smith; N H Smith; M O'Rourke; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995.

Authors:  J Y Riou; S Djibo; L Sangare; J P Lombart; P Fagot; J P Chippaux; M Guibourdenche
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

8.  Capsule switching of Neisseria meningitidis.

Authors:  J S Swartley; A A Marfin; S Edupuganti; L J Liu; P Cieslak; B Perkins; J D Wenger; D S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

9.  Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980.

Authors:  D Hansman
Journal:  J Hyg (Lond)       Date:  1983-02

10.  The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community.

Authors:  I S Blakebrough; B M Greenwood; H C Whittle; A K Bradley; H M Gilles
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

View more
  14 in total

1.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Neisseria meningitidis serogroup X sequence type 767 in Turkey.

Authors:  Abdullah Kiliç; Orhan Bedir; A Celal Basustaoglu; Holly B Bratcher; Keith A Jolley; Gurkan Mert
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

3.  Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case.

Authors:  Gönül Tanır; Yasemin Ozsurekci; Jay Lucidarme; Sevgi Yaşar Durmuş; Aiswarya Lekshmi; Özlem Akisoglu; Ahmet Emre Aycan; Ray Borrow; Mehmet Ceyhan
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

4.  Neisseria meningitidis serogroup X sequence type 2888, Italy.

Authors:  Cecilia Fazio; Stefania Starnino; Marina Dal Solda; Tonino Sofia; Arianna Neri; Paola Mastrantonio; Paola Stefanelli
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Authors:  Francesca Micoli; Maria Rosaria Romano; Marta Tontini; Emilia Cappelletti; Massimiliano Gavini; Daniela Proietti; Simona Rondini; Erwin Swennen; Laura Santini; Sara Filippini; Cristiana Balocchi; Roberto Adamo; Gerd Pluschke; Gunnstein Norheim; Andrew Pollard; Allan Saul; Rino Rappuoli; Calman A MacLennan; Francesco Berti; Paolo Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

6.  Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.

Authors:  P T Beernink; D A Caugant; J A Welsch; O Koeberling; D M Granoff
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

7.  Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.

Authors:  Ana Belén Ibarz-Pavón; Luis Morais; Betuel Sigaúque; Inacio Mandomando; Quique Bassat; Ariel Nhacolo; Llorenç Quintó; Montse Soriano-Gabarró; Pedro L Alonso; Anna Roca
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

8.  Serogroup X in meningococcal disease, Western Kenya.

Authors:  Sadiki Materu; Helen S Cox; Petros Isaakidis; Bienvenu Baruani; Thomas Ogaro; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

9.  Meningococcal disease: changes in epidemiology and prevention.

Authors:  Qiuzhi Chang; Yih-Ling Tzeng; David S Stephens
Journal:  Clin Epidemiol       Date:  2012-09-19       Impact factor: 4.790

10.  Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.

Authors:  Timo Vesikari; Aino Forstén; Dominique Boutriau; Véronique Bianco; Marie Van der Wielen; Jacqueline M Miller
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.